Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...

eXoZymes Inc. is featured on the cover of the April issue of GEN Biotechnology with a paper introducing the term "exozymes" to clarify the concept of cell-free biomanufacturing, which produces ...

Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...

Enzymit and Cosun achieve a major milestone in sustainable biomanufacturing, producing high-purity hyaluronic acid with a novel cell-free process that offers unmatched control over molecular profile.

Elegen has launched ENFINIA™ IVT Ready DNA, a cell-free gene synthesis platform that provides full-length linear DNA templates encoded poly(A) tails for in vitro transcription. The templates are ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...